« Pfizer says R&D Should Shrink | Main | Pfizer Walks Tightrope with Potential Blockbuster RA Drug News »

04/25/2011

TrackBack

TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a0120a77f675b970b01538e1dce3b970b

Listed below are links to weblogs that reference Next Alzheimer's Hope Step Forward:

Comments

Feed You can follow this conversation by subscribing to the comment feed for this post.

gup1138

My also-flawed understanding agrees @bigredbrurce - the mAb is targeted at soluble A-beta, thus helping it to be 'cleared' out of the body - and preventing it 1) from participating in plaque formation AS WELL AS 2) interfering with synaptic communications (which apparently the soluble forms - 'dimers' of two A-beta proteins - and more, 'oligomers' - do very effectively, disrupting synaptic transmission).

bigredbruce

My understanding may be flawed but I believe the mAb is directed at soluble amyloid beta in the blood and thus renders this circulating material unavailable to participate in plaque formation.

Fai

i still cannot understand how does an antibody cross the blood brain barrier. I think modular antibody will have better chance. We had discussion about this drug like 7-8 years ago, and most of us don't think it is possible at the time to work. I hope it work, cause AD is a horrible disease.

The comments to this entry are closed.

My Photo
Blog powered by Typepad
Member since 12/2009
Bookmark and Share

July 2014

Sun Mon Tue Wed Thu Fri Sat
    1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31    

Innovate on Purpose

In the Pipeline

Life Sci VC


visited 6 states (46.1%)
Create your own visited map of Canada